How did BPMC's Q1 2024 EPS surprise analysts?
4/6/2025 11:29am
Blueprint Medicines (BPMC) reported a diluted EPS of $1.4 for Q1 2024, which was a surprise of $0.34, or 32.1%, higher than analysts' expectations.
|code|Ticker|Name|Date|EPS Surprise|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|BPMC|BPMC.O|Blueprint Medicines|2023 Q2|0.39|-2.19|185|
|BPMC|BPMC.O|Blueprint Medicines|2023 Q3|0.17|-2.2|185|
|BPMC|BPMC.O|Blueprint Medicines|2023 Q4|0.22||185|
|BPMC|BPMC.O|Blueprint Medicines|2024 Q1|0.34|1.4|185|